-
Rupintrivir (AG-7088, Rupinavir) is a
peptidomimetic antiviral drug
which acts as a 3C and 3CL
protease inhibitor. It was
developed for the treatment...
- picornaviruses,
include the following:
Rupintrivir is a
peptidomimetic drug
developed for
treatment of
rhinovirus infections.
Rupintrivir inhibits human rhinovirus...
- for the
replication of the
virus responsible for COVID-19. 3CLpro-1
Rupintrivir Yang L, Wang Z (September 2023). "Bench-to-bedside:
Innovation of small...
-
developed targeting 3CLpro and
homologous 3Cpro,
including CLpro-1, GC376,
rupintrivir, lufotrelvir, PF-07321332, and AG7404. The
intravenous administered prodrug...
- drug
targeting 3C
protease is in the
market yet, but
inhibitors such as
rupintrivir and
pyrazoles show
promising targeting in
broad range of picornaviruses...
-
rufinamide (INN)
rufloxacin (INN)
rufocromomycin (INN) Rum-K
rupatadine (INN)
Rupintrivir (USAN)
ruplizumab (INN)
rurioctocog alfa
pegol (INN)
Rusalactide (USAN)...
- (–trelvir) Ensitrelvir†
Ibuzatrelvir Lufotrelvir Nirmatrelvir† (+ritonavir)†
Rupintrivir Simnotrelvir (+ritonavir†) RNA pol
inhibitors CMX521§ Deuremidevir† Favipiravir...
- 3CLpro-1 is an
antiviral drug
related to
rupintrivir which acts as a 3CL
protease inhibitor and was
originally developed for the
treatment of
human enterovirus...
- coxsackievirus, and also has
activity against parechoviruses.
Pleconaril Rupintrivir Lentz KN,
Smith AD,
Geisler SC, Cox S,
Buontempo P,
Skelton A, DeMartino...
-
blocking the enzyme's
normal function. 3CLpro-1
Carmofur Ebselen GRL-0617
Rupintrivir Theaflavin digallate Paxlovid "Anivive". www.anivive.com.
Retrieved 2020-05-14...
